|
Volumn 41, Issue 4, 2001, Pages 424-428
|
Obstetric and neonatal outcomes associated with maternal naltrexone exposure
a b c d
c
Lisbon Portugal
*
(Portugal)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANESTHETIC AGENT;
DIAMORPHINE;
METHADONE;
NALOXONE;
NALTREXONE;
SEDATIVE AGENT;
ADULT;
APGAR SCORE;
ARTICLE;
AUSTRALIA;
BIRTH WEIGHT;
BLEEDING;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONCEPTION;
CONTROLLED STUDY;
DELIVERY;
DISEASE ASSOCIATION;
DRUG DETOXIFICATION;
DRUG EXPOSURE;
DRUG WITHDRAWAL;
FEMALE;
FETUS DEVELOPMENT;
FETUS RISK;
GESTATIONAL AGE;
HEAD CIRCUMFERENCE;
HUMAN;
INCIDENCE;
LOW BIRTH WEIGHT;
MAINTENANCE THERAPY;
MEDICAL INFORMATION;
NEWBORN;
NEWBORN MORTALITY;
PORTUGAL;
PREGNANCY COMPLICATION;
PRIORITY JOURNAL;
SUBSTANCE ABUSE;
TERATOGENICITY;
THIRD TRIMESTER PREGNANCY;
ULTRASOUND;
UNITED KINGDOM;
ADULT;
AUSTRALIA;
FEMALE;
GREAT BRITAIN;
HEROIN DEPENDENCE;
HUMANS;
INFANT, NEWBORN;
NALTREXONE;
NARCOTIC ANTAGONISTS;
PORTUGAL;
PREGNANCY;
PREGNANCY COMPLICATIONS;
PREGNANCY OUTCOME;
PREGNANCY TRIMESTERS;
|
EID: 0035185258
PISSN: 00048666
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1479-828X.2001.tb01322.x Document Type: Article |
Times cited : (46)
|
References (14)
|